These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7018376)

  • 1. [Growth factors with identical insulino-situations : IGF I and II, NSILA and somatomedins (author's transl)].
    Froesch ER; Zapf J
    Ann Endocrinol (Paris); 1980; 41(6):502-11. PubMed ID: 7018376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent data on somatomedins (insulin-like growth factors) (author's transl)].
    Binoux M
    Ann Endocrinol (Paris); 1980; 41(3):157-92. PubMed ID: 6998350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergence of binding sites, in vitro action, and secretory regulation of the somatomedin peptides, IGF-I and IGF-II.
    Daughaday WH
    Proc Soc Exp Biol Med; 1982 Jul; 170(3):257-63. PubMed ID: 7045880
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a receptor for somatomedin-like polypeptides in human fibroblasts.
    Rechler MM; Nissley SP; Podskalny JM; Moses AC; Fryklund L
    J Clin Endocrinol Metab; 1977 May; 44(5):820-31. PubMed ID: 192752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4379-81. PubMed ID: 1069990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid molecules containing the B-domain of insulin-like growth factor I are recognized by carrier proteins of the growth factor.
    De Vroede MA; Rechler MM; Nissley SP; Joshi S; Burke GT; Katsoyannis PG
    Proc Natl Acad Sci U S A; 1985 May; 82(9):3010-4. PubMed ID: 2581261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatomedins (author's transl)].
    Binoux M
    Sem Hop; 1981 May 8-15; 57(17-18):923-8. PubMed ID: 6165086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Competitive protein-binding assay for somatomedins and their carrier protein (author's transl)].
    Binoux M; Lassarre C; Seurin D
    Ann Endocrinol (Paris); 1980; 41(1):67-9. PubMed ID: 7396401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific insulin-like growth factor (IGF) I- and II-binding sites on rat granulosa cells: relation to IGF action.
    Davoren JB; Kasson BG; Li CH; Hsueh AJ
    Endocrinology; 1986 Nov; 119(5):2155-62. PubMed ID: 2945713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of insulinlike growth factor I binding to human fibroblast monolayer cultures by insulinlike growth factor carrier proteins released to the incubation media.
    De Vroede MA; Tseng LY; Katsoyannis PG; Nissley SP; Rechler MM
    J Clin Invest; 1986 Feb; 77(2):602-13. PubMed ID: 2418066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta.
    King GL; Goodman AD; Buzney S; Moses A; Kahn CR
    J Clin Invest; 1985 Mar; 75(3):1028-36. PubMed ID: 2984251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of insulin-like growth factors with a nonfusing mouse muscle cell line: binding, action, and receptor down-regulation.
    de Vroede MA; Romanus JA; Standaert ML; Pollet RJ; Nissley SP; Rechler MM
    Endocrinology; 1984 May; 114(5):1917-29. PubMed ID: 6325137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins.
    Rechler MM; Zapf J; Nissley SP; Froesch ER; Moses AC; Podskalny JM; Schilling EE; Humbel RE
    Endocrinology; 1980 Nov; 107(5):1451-9. PubMed ID: 6159199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of somatomedin-A and -C, NSILA-S and insulin to human placental cell membranes.
    van Buul-Offers S; Van den Brande JL
    Horm Res; 1979; 11(4):186-202. PubMed ID: 227778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs.
    Schlumpf U; Heimann R; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1976 Jan; 81(1):28-42. PubMed ID: 946140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.
    Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA
    Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of the IGF (insulin-like growth factors or somatomedins) competitive binding assay in the study of growth disorders in children (results for 124 observations) (author's transl)].
    Gourmelen M; Girard F; Binoux M
    Arch Fr Pediatr; 1980; 37 Suppl 2():XXXIII-XXXVIII. PubMed ID: 7447617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biosynthesis and hormonal regulation of IGF (insulin-like growth factors, or somatomedins). Experimental and clinical studies (author's transl)].
    Binoux M; Hossenlopp P; Gourmelen M; Girard F
    Ann Endocrinol (Paris); 1980; 41(6):487-94. PubMed ID: 7018374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture.
    Myal Y; Shiu RP; Bhaumick B; Bala M
    Cancer Res; 1984 Dec; 44(12 Pt 1):5486-90. PubMed ID: 6093996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.